https://sputnikglobe.com/20201231/china-approves-public-use-of-sinopharm-vaccine-against-covid-19--reports-1081616171.html
China Approves Public Use of Sinopharm Vaccine Against COVID-19 – Reports
China Approves Public Use of Sinopharm Vaccine Against COVID-19 – Reports
Sputnik International
BEIJING (Sputnik) – China’s National Medical Products Administration authorized on Thursday the public use of the Sinopharm vaccine against the coronavirus... 31.12.2020, Sputnik International
2020-12-31T03:48+0000
2020-12-31T03:48+0000
2020-12-31T03:50+0000
https://cdn1.img.sputnikglobe.com/img/07e4/0c/1f/1081616136_0:310:3072:2048_1920x0_80_0_0_4b33acc8b3e97a8439f6bcfbd4f78b4c.jpg
china
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2020
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
newsfeed, china, vaccine, coronavirus
newsfeed, china, vaccine, coronavirus
China Approves Public Use of Sinopharm Vaccine Against COVID-19 – Reports
03:48 GMT 31.12.2020 (Updated: 03:50 GMT 31.12.2020) BEIJING (Sputnik) – China’s National Medical Products Administration authorized on Thursday the public use of the Sinopharm vaccine against the coronavirus, the China Central Television reported.
On Wednesday, Sinopharm’s subsidiary Beijing Institute of Biological Products said that the efficiency of its vaccine had exceeded 79 percent. The vaccine has already been approved by Bahrain and the United Arab Emirates.
The scientists will reportedly continue to study the efficiency of the vaccine.
According to earlier statements of Sinopharm, about 1 million people have already been vaccinated with its drug, including 60,000 people outside China.
